1. Anti-cancer stem cell drug starts clinical trials By: Vito Randazzo OncoMed Pharmaceuticals Inc., is currently developing therapeutic drugs that target cancer stem cells. The dosing and study for effectiveness of the drug has commenced in a Phase 1 clinical trial of OMP-59R5 in patients with advanced solid tumor cancers.